LSBio The Immunohistochemistry Antibody Company
  • Home
  • Products
    • All Antibodies
    • IHC-plus Antibodies
  • Services
    • Immunohistochemistry Studies
    • Tissue Cross-Reactivity Screening
  • Distributors
  • Resources
    • About our Tissue Bank
    • Customer Support
    • How to Buy
    • IHC-plus Protocol
    • LSBio Media
    • Publications
    • Antibody Reports
  • Company
    • About LifeSpan
    • Press Releases
    • Holiday Schedule
    • Contact Us
  • View Cart

Breast Cancer Screen 89 Tissue Microarray - LS-SBRCA89

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Catalog ID: LS-SBRCA89
Product Name: Breast Cancer Screen 89
Description: Medullary carcinoma of breast
Format: FFPE
Category: Human Tumor
QA/QC: H&E reviewed; IHC validated with a positive control antibody
Storage: Short term RT; Long term 4ºC
Clinical History: No
Tissue Marker: No
Stage/Grade: No
Core Diameter: 1.5 mm
Core Thickness: 5 µm
Cases: 80
Cores: 80
Slides Per Set: 1

LS-SBRCA89 Tissue Microarray Map

Slide Number 1
LABEL
 12345678910
ABstBstBstBstBstBstBstBstBstBst
BBstBstBstBstBstBstBstBstBstBst
CBstBstBstBstBstBstBstBstBstBst
DBstBstBstBstBstBstBstBstBstBst
EBstBstBstBstBstBstBstBstBstBst
FBstBstBstBstBstBstBstBstBstBst
GBstBstBstBstBstBstBstBstBstBst
HBstBstBstBstBstBstBstBstBstBst
Diagnosis Type Legend
Benign non-neoplasticDiseasedInflammatoryMalignantMetastaticTumorUnknown
Element Tissue Legend
Breast (Bst);

LS-SBRCA89 Element Details

SlidePositionSpeciesGenderAgeTissueDiagnosisDiagnosis Type
1A1HumanF53 yBreast (Bst)Medullary carcinomaMalignant
1A2HumanF60 yBreast (Bst)Medullary carcinomaMalignant
1A3HumanF51 yBreast (Bst)Medullary carcinomaMalignant
1A4HumanF31 yBreast (Bst)Medullary carcinomaMalignant
1A5HumanF52 yBreast (Bst)Medullary carcinomaMalignant
1A6HumanF53 yBreast (Bst)Medullary carcinomaMalignant
1A7HumanF43 yBreast (Bst)Medullary carcinomaMalignant
1A8HumanF48 yBreast (Bst)Medullary carcinomaMalignant
1A9HumanF51 yBreast (Bst)Medullary carcinomaMalignant
1A10HumanF31 yBreast (Bst)Medullary carcinomaMalignant
1B1HumanF34 yBreast (Bst)Medullary carcinomaMalignant
1B2HumanF70 yBreast (Bst)Medullary carcinomaMalignant
1B3HumanF60 yBreast (Bst)Medullary carcinomaMalignant
1B4HumanF55 yBreast (Bst)Medullary carcinomaMalignant
1B5HumanF34 yBreast (Bst)Medullary carcinomaMalignant
1B6HumanF55 yBreast (Bst)Medullary carcinomaMalignant
1B7HumanF79 yBreast (Bst)Medullary carcinomaMalignant
1B8HumanF48 yBreast (Bst)Medullary carcinomaMalignant
1B9HumanF60 yBreast (Bst)Medullary carcinomaMalignant
1B10HumanF35 yBreast (Bst)Medullary carcinomaMalignant
1C1HumanF40 yBreast (Bst)Medullary carcinomaMalignant
1C2HumanF46 yBreast (Bst)Medullary carcinomaMalignant
1C3HumanF61 yBreast (Bst)Medullary carcinomaMalignant
1C4HumanF58 yBreast (Bst)Medullary carcinomaMalignant
1C5HumanF47 yBreast (Bst)Medullary carcinomaMalignant
1C6HumanF27 yBreast (Bst)Medullary carcinomaMalignant
1C7HumanF64 yBreast (Bst)Medullary carcinoma with necrosisMalignant
1C8HumanF55 yBreast (Bst)Medullary carcinomaMalignant
1C9HumanF51 yBreast (Bst)Medullary carcinomaMalignant
1C10HumanF59 yBreast (Bst)Medullary carcinomaMalignant
1D1HumanF41 yBreast (Bst)Medullary carcinomaMalignant
1D2HumanF55 yBreast (Bst)Medullary carcinomaMalignant
1D3HumanF32 yBreast (Bst)Medullary carcinomaMalignant
1D4HumanF45 yBreast (Bst)CarcinomaMalignant
1D5HumanF49 yBreast (Bst)Medullary carcinomaMalignant
1D6HumanF55 yBreast (Bst)Medullary carcinomaMalignant
1D7HumanF48 yBreast (Bst)Medullary carcinomaMalignant
1D8HumanF39 yBreast (Bst)Medullary carcinomaMalignant
1D9HumanF39 yBreast (Bst)Medullary carcinomaMalignant
1D10HumanF45 yBreast (Bst)Medullary carcinomaMalignant
1E1HumanF47 yBreast (Bst)Medullary carcinomaMalignant
1E2HumanF58 yBreast (Bst)Medullary carcinomaMalignant
1E3HumanF32 yBreast (Bst)Medullary carcinomaMalignant
1E4HumanF32 yBreast (Bst)Medullary carcinomaMalignant
1E5HumanF35 yBreast (Bst)Medullary carcinomaMalignant
1E6HumanF48 yBreast (Bst)Medullary carcinomaMalignant
1E7HumanF42 yBreast (Bst)Medullary carcinomaMalignant
1E8HumanF41 yBreast (Bst)CarcinomaMalignant
1E9HumanF55 yBreast (Bst)Medullary carcinomaMalignant
1E10HumanF70 yBreast (Bst)Medullary carcinomaMalignant
1F1HumanF42 yBreast (Bst)CarcinomaMalignant
1F2HumanF42 yBreast (Bst)Medullary carcinomaMalignant
1F3HumanF42 yBreast (Bst)Medullary carcinomaMalignant
1F4HumanF69 yBreast (Bst)Medullary carcinomaMalignant
1F5HumanF42 yBreast (Bst)Medullary carcinomaMalignant
1F6HumanF38 yBreast (Bst)Medullary carcinomaMalignant
1F7HumanF38 yBreast (Bst)Medullary carcinomaMalignant
1F8HumanF35 yBreast (Bst)Medullary carcinomaMalignant
1F9HumanF34 yBreast (Bst)Medullary carcinomaMalignant
1F10HumanF43 yBreast (Bst)Medullary carcinomaMalignant
1G1HumanF48 yBreast (Bst)Medullary carcinomaMalignant
1G2HumanF43 yBreast (Bst)Medullary carcinomaMalignant
1G3HumanF45 yBreast (Bst)Medullary carcinomaMalignant
1G4HumanF59 yBreast (Bst)Medullary carcinomaMalignant
1G5HumanF53 yBreast (Bst)Medullary carcinomaMalignant
1G6HumanF47 yBreast (Bst)Medullary carcinomaMalignant
1G7HumanF51 yBreast (Bst)Medullary carcinomaMalignant
1G8HumanF38 yBreast (Bst)Medullary carcinomaMalignant
1G9HumanF40 yBreast (Bst)Medullary carcinomaMalignant
1G10HumanF42 yBreast (Bst)Medullary carcinomaMalignant
1H1HumanF54 yBreast (Bst)Medullary carcinomaMalignant
1H2HumanF44 yBreast (Bst)Medullary carcinomaMalignant
1H3HumanF46 yBreast (Bst)Medullary carcinomaMalignant
1H4HumanF64 yBreast (Bst)Medullary carcinomaMalignant
1H5HumanF42 yBreast (Bst)Medullary carcinomaMalignant
1H6HumanF69 yBreast (Bst)Medullary carcinomaMalignant
1H7HumanF34 yBreast (Bst)Medullary carcinomaMalignant
1H8HumanF54 yBreast (Bst)Medullary carcinomaMalignant
1H9HumanF55 yBreast (Bst)Medullary carcinomaMalignant
1H10HumanF47 yBreast (Bst)Medullary carcinomaMalignant
PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.

Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved